Transforming growth factor (TGF)-β signaling in cardiac remodeling.
about
The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial HypertensionObesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunitiesGood and bad sides of TGFβ-signaling in myocardial infarctionPolymorphisms and plasma level of transforming growth factor-Beta 1 and risk for preeclampsia: a systematic reviewThe physiology of cardiovascular disease and innovative liposomal platforms for therapyPitx2c is reactivated in the failing myocardium and stimulates myf5 expression in cultured cardiomyocytesCardiac fibrosis in myocardial infarction-from repair and remodeling to regenerationMicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4Cucurbitacin I Attenuates Cardiomyocyte Hypertrophy via Inhibition of Connective Tissue Growth Factor (CCN2) and TGF- β/Smads SignalingsEstablishment of a prediction model of changing trends in cardiac hypertrophy disease based on microarray data screening.Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways.Association of the common genetic polymorphisms and haplotypes of the chymase gene with left ventricular mass in male patients with symptomatic aortic stenosis.Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contractionAdult murine cardiomyocytes exhibit regenerative activity with cell cycle reentry through STAT3 in the healing process of myocarditis.The calcium release-activated calcium channel Orai1 represents a crucial component in hypertrophic compensation and the development of dilated cardiomyopathy.The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart.SHSST cyclodextrin complex prevents the fibrosis effect on CCl₄-induced cirrhotic cardiomyopathy in rats through TGF-β pathway inhibition effects.Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition.Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunctionHeart failure with preserved ejection fraction: molecular pathways of the aging myocardiumThe Notch pathway controls fibrotic and regenerative repair in the adult heart.Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study.Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction.Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor betaAndrogens contribute to sex differences in myocardial remodeling under pressure overload by a mechanism involving TGF-β.Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-β/smad2/3 pathway.Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation.Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine.Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future InvestigationEnhanced sensitivity to low dose irradiation of ApoE-/- mice mediated by early pro-inflammatory profile and delayed activation of the TGFβ1 cascade involved in fibrogenesis.Krüppel-like factor 4 transcriptionally regulates TGF-β1 and contributes to cardiac myofibroblast differentiation.The overexpression of Twinkle helicase ameliorates the progression of cardiac fibrosis and heart failure in pressure overload model in mice.Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodelingSmad3 inactivation and MiR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat.The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure.Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathyCardiac steatosis potentiates angiotensin II effects in the heart.Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery diseaseThe complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophyPharmacological inhibition of TGFβ receptor improves Nkx2.5 cardiomyoblast-mediated regeneration
P2860
Q26744761-EBF759F9-D596-4EED-8685-A6B7A8C64583Q26825697-817A92F0-ACDE-4902-BDE3-D95DC7D32249Q26863465-5D00BD82-0E01-4038-879F-FE05FE4E83D3Q26865949-B26E8C12-82F2-43C7-A88D-8A24180A2CF5Q27002949-45EC6752-BBF5-4D12-81AF-2752E9A21A67Q27318048-C69C3959-604D-4AC2-A541-FC0AB6F2E0C2Q28068468-A7E7A742-14D8-43EF-9217-CB7760399138Q28118775-810E9B86-03C5-4E6A-A45C-519D36A80F93Q28547428-8130F576-E979-409A-977A-61E0E50F2915Q31095420-B2BF7038-20AF-417F-9090-BBAF4F96D77EQ33603596-86BD9E92-3D41-4984-B159-7ED854A4FCD7Q33604328-806B9052-2C0B-4E86-BE17-461EFD485707Q33648136-D3E35B05-349A-4D27-A4E5-21D95FEE05D2Q33684123-5118AE09-D6F0-4097-AAAC-2E53F95CB610Q33721878-100E03E2-25F1-42EC-ACC4-8233935EC916Q33737254-3E9EA73E-47C0-4D91-8BC4-BB8923F497A8Q33755691-B32EB50E-CB79-4E8C-BC56-938B7328E159Q33790719-16B188D1-3827-490F-8A7A-E7FBDDE2BA98Q33877795-6A9FC71C-013F-467D-B8C5-AD3DB87BB262Q33889242-940F8F78-CDC3-446E-8B2A-1F8D5BA79178Q34071933-D89D072F-2740-45E8-9230-FB94DB2177A3Q34076151-9A5394E6-52A4-4257-A243-D1064C9F496EQ34089713-65A2EC77-E7D5-47B7-8246-2B83E5462146Q34211886-0703DA87-A882-4496-8EED-AF2EFA989FB8Q34256551-217C937A-805A-4D09-A394-89AF351D1079Q34258422-90EEC614-1365-4CF1-A082-837ED1075540Q34295008-9DF909B0-B9D7-4E65-9B50-4AF9D6E271B5Q34340857-872B448F-8144-43AE-8991-C1EC843D9DA8Q34520504-0249E8B8-38AA-45EF-B04A-4616552F6C47Q34602939-72CDF4B4-8477-47BC-85F2-FF44BAE51250Q34707131-EB16BF33-FA9E-4BC8-BACE-33802114E306Q34807853-D9AC8861-CD6E-40E5-9A19-3D7FB99C1596Q34891653-C18A970B-DC95-4E94-BEDA-665B7CB0E958Q35005754-F74A3021-E7F0-4C88-A479-5ABE383D267DQ35065245-4B33984B-4E5F-4AEF-8346-03C068AB717DQ35071386-DCB8EBAF-FB67-42A5-9DE0-A9192D0E9AF6Q35086438-E097CB28-8D7F-474A-B7BD-E7563B1975FBQ35095828-EF6953C9-13E7-4B52-935F-5EDD714935CDQ35125156-F97DFD92-1A7E-441C-8279-021941BE3478Q35127231-50A24E49-323B-4EAC-93A2-F93F10AECFDD
P2860
Transforming growth factor (TGF)-β signaling in cardiac remodeling.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Transforming growth factor (TGF)-β signaling in cardiac remodeling.
@en
type
label
Transforming growth factor (TGF)-β signaling in cardiac remodeling.
@en
prefLabel
Transforming growth factor (TGF)-β signaling in cardiac remodeling.
@en
P2860
P1476
Transforming growth factor (TGF)-β signaling in cardiac remodeling
@en
P2093
Marcin Dobaczewski
P2860
P304
P356
10.1016/J.YJMCC.2010.10.033
P577
2010-11-06T00:00:00Z